» Articles » PMID: 31115532

Bioinformatics Identification of MicroRNAs Involved In polycystic Ovary Syndrome Based on Microarray Data

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2019 May 23
PMID 31115532
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disease in women of reproductive age. MicroRNAs (miRNAs or miRs) serve important roles in the physiological and pathological process of PCOS. To identify PCOS‑associated miRNAs, the dataset GSE84376 was extracted from the Gene Expression Omnibus database. Differentially expressed miRNAs (DE‑miRNAs) were obtained from Gene‑Cloud Biotechnology Information and potential target genes were predicted using TargetScan, DIANA‑microT‑CDS, miRDB and miRTarBase tools. Gene Ontology enrichment analysis was performed using Metascape and a protein‑protein interaction network was constructed using Cytoscape. Transcription factors were obtained from FunRich. DE‑miRNAs were verified by reverse transcription‑quantitative PCR. At the screening phase, there were seven DE‑miRNAs in the PCOS group not present in the control group. In total, 935 target genes were identified, which are involved in the development and maturation of oocytes. Mitogen‑activated protein kinase 1, phosphatase and tensin homolog, cAMP responsive element binding protein 1, signal transducer and activator of transcription 3, interferon γ, Fms‑related tyrosine kinase 1, transcription factor p65, insulin receptor substrate 1, DnaJ homolog superfamily C member 10 and casein kinase 2 α 1 were identified as the top 10 hub genes in the protein‑protein interaction network. Specificity protein 1 was the most enriched transcription factor. At the validation phase, the levels of Homo sapiens (hsa)‑miR‑3188 and hsa‑miR‑3135b were significantly higher in the PCOS group than in the control group. In addition, the expression level of hsa‑miR‑3135b was significantly correlated with the number of oocytes retrieved, the fertilization rate and the cleavage rate (P<0.05). The present bioinformatics study on miRNAs may offer a novel understanding of the mechanism of PCOS, and may serve to identify novel miRNA therapeutic targets.

Citing Articles

Mechanism of YJKL Decoction in Treating of PCOS Infertility by Integrative Approach of Network Pharmacology and Experimental Verification.

Zhang R, Xu W, Wei H, Li B, Wang Y, He X Drug Des Devel Ther. 2024; 18:3853-3870.

PMID: 39219692 PMC: 11366254. DOI: 10.2147/DDDT.S456656.


Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.

Heidarzadehpilehrood R, Pirhoushiaran M, Osman M, Ling K, Hamid H Iran J Pharm Res. 2024; 22(1):e139985.

PMID: 38444712 PMC: 10912876. DOI: 10.5812/ijpr-139985.


Understanding the underlying genetic mechanisms for age at first calving, inter-calving period and scrotal circumference in Bonsmara cattle.

Reding J, van der Westhuizen R, Berry D, van Marle-Koster E BMC Genomics. 2023; 24(1):480.

PMID: 37620802 PMC: 10464233. DOI: 10.1186/s12864-023-09518-8.


Weighted Gene Co-Expression Network Analysis (WGCNA) Discovered Novel Long Non-Coding RNAs for Polycystic Ovary Syndrome.

Heidarzadehpilehrood R, Pirhoushiaran M, Osman M, Hamid H, Ling K Biomedicines. 2023; 11(2).

PMID: 36831054 PMC: 9953234. DOI: 10.3390/biomedicines11020518.


Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K/AKT signaling.

Yang X, Wang K, Lang J, Guo D, Gao H, Qiu Y BMC Womens Health. 2022; 22(1):412.

PMID: 36209087 PMC: 9548189. DOI: 10.1186/s12905-022-01994-6.


References
1.
Yagi T, Takeichi M . Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev. 2000; 14(10):1169-80. View

2.
Nelson L, Bulun S . Estrogen production and action. J Am Acad Dermatol. 2001; 45(3 Suppl):S116-24. DOI: 10.1067/mjd.2001.117432. View

3.
Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

4.
Mitchell L, Kennedy C, Hartshorne G . Expression of nitric oxide synthase and effect of substrate manipulation of the nitric oxide pathway in mouse ovarian follicles. Hum Reprod. 2003; 19(1):30-40. DOI: 10.1093/humrep/deh032. View

5.
. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2003; 19(1):41-7. DOI: 10.1093/humrep/deh098. View